[Palliative treatment of hepatocellular carcinoma]

Gastroenterol Clin Biol. 2006 Jun-Jul;30(6-7):887-90. doi: 10.1016/s0399-8320(06)73337-1.
[Article in French]
No abstract available

Publication types

  • Review

MeSH terms

  • Aged
  • Antibiotics, Antineoplastic / administration & dosage*
  • Antineoplastic Agents / administration & dosage*
  • Carcinoma, Hepatocellular / mortality
  • Carcinoma, Hepatocellular / therapy*
  • Chemoembolization, Therapeutic*
  • Cisplatin / administration & dosage*
  • Data Interpretation, Statistical
  • Doxorubicin / administration & dosage*
  • Humans
  • Interferon-alpha / administration & dosage
  • Interferon-alpha / therapeutic use
  • Liver Neoplasms / mortality
  • Liver Neoplasms / therapy*
  • Meta-Analysis as Topic
  • Palliative Care
  • Prognosis
  • Quality of Life
  • Randomized Controlled Trials as Topic
  • Retrospective Studies
  • Risk Factors
  • Time Factors
  • Treatment Outcome

Substances

  • Antibiotics, Antineoplastic
  • Antineoplastic Agents
  • Interferon-alpha
  • Doxorubicin
  • Cisplatin